Show simple item record

P648 The impact of infliximab therapeutic drug monitoring on decisions made in a virtual biologics clinic for IBD

dc.contributor.authorSelinger, C.en
dc.contributor.authorLenti, M.en
dc.contributor.authorClark, T.en
dc.contributor.authorRafferty, H.en
dc.contributor.authorO'Connor, A.en
dc.contributor.authorAhmad, Tariqen
dc.contributor.authorHamlin, J.en
dc.date.accessioned2017-02-14T10:41:09Z
dc.date.available2017-02-14T10:41:09Z
dc.date.issued2017-02-01
dc.identifier.citationP648 The impact of infliximab therapeutic drug monitoring on decisions made in a virtual biologics clinic for IBD 2017, 11 (suppl_1):S411 Journal of Crohn's and Colitisen
dc.identifier.issn1873-9946
dc.identifier.issn1876-4479
dc.identifier.doi10.1093/ecco-jcc/jjx002.772
dc.identifier.urihttp://hdl.handle.net/11287/620221
dc.language.isoenen
dc.publisherOxford Journalsen
dc.relation.urlhttps://academic.oup.com/ecco-jcc/ecco-jcc/article/2961591/P648en
dc.rightsArchived with thanks to Journal of Crohn's and Colitisen
dc.subjectWessex Classification Subject Headings::Gastroenterologyen
dc.titleP648 The impact of infliximab therapeutic drug monitoring on decisions made in a virtual biologics clinic for IBDen
dc.typeConference abstracten
dc.identifier.journalJournal of Crohn's and Colitisen
dc.type.versionPublisheden


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record